Microtome Market

Executive Summary

Microtome Market was valued at US $159.97 million in 2021 and is projected to grow at 5.94% CAGR over the forecast period to reach US $226.15 million by 2027. Microtome Market represented US $17.44 million opportunity over 2019-2021 and estimated to create US $66.18 million opportunity in 2027 over 2021.

Microtome from Consainsights analyses the Microtome Market in the Life Sciences industry over the forecast period to 2027.

Microtome research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Microtome segmentation includes Product, Application, Technology, End User, Region and Geography.

Based on the Product, the Microtome analysis covers Microtome Instruments, Microtome Accessories.

In Product segment, Microtome Instruments segment has highest cagr growth of 5.26%.

Based on the Application, the Microtome analysis covers Disease Diagnosis, Medical Research.

In Application segment, Disease Diagnosis segment has highest cagr growth of 5.26%.

Based on the Technology, the Microtome analysis covers Manual Microtomes, Semi-Automated Microtomes, Fully Automated Microtomes.

In Technology segment, Manual Microtomes segment has highest cagr growth of 5.26%.

Based on the End User, the Microtome analysis covers Hospital Laboratories, Clinical Laboratories, Other End Users.

In End User segment, Hospital Laboratories segment has highest cagr growth of 5.26%.

Based on the Region, the Microtome analysis covers North America, Europe, Asia Pacific, Rest of the World.

In Region segment, North America segment has highest cagr growth of 5.26%.

Based on the region, the Microtome analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Amos Scientific Pty Ltd, Danaher, Diapath S.p.A., Histo-Line Laboratories, Jinhua YIDI Medical Appliance Co.,Ltd, MEDITE GmbH, RMC Boeckeler, Sakura Finetek, SLEE Medical GmbH, Thermo Fisher Scientific and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Microtome Instruments segment has the highest revenue of US $155.33 million and is expected to grow at CAGR of 5.26% by 2027 Microtome Instruments segment has highest cagr growth of 5.26%.

Microtome Instruments

Microtome Instruments segment was valued at US $138.40 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $219.59 million by 2027. Microtome Instruments segment represented US $16.93 million opportunity over 2019-2021 and estimated to create US $64.26 million opportunity in 2027 over 2021.

Microtome Accessories

Microtome Accessories segment was valued at US $4.13 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $6.56 million by 2027. Microtome Accessories segment represented US $0.51 million opportunity over 2019-2021 and estimated to create US $1.92 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Disease Diagnosis segment has the highest revenue of US $154.63 million and is expected to grow at CAGR of 5.26% by 2027 Disease Diagnosis segment has highest cagr growth of 5.26%.

Disease Diagnosis

Disease Diagnosis segment was valued at US $137.78 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $218.60 million by 2027. Disease Diagnosis segment represented US $16.85 million opportunity over 2019-2021 and estimated to create US $63.97 million opportunity in 2027 over 2021.

Medical Research

Medical Research segment was valued at US $4.76 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $7.55 million by 2027. Medical Research segment represented US $0.58 million opportunity over 2019-2021 and estimated to create US $2.21 million opportunity in 2027 over 2021.

Technology

Introduction

In 2021, Manual Microtomes segment has the highest revenue of US $110.52 million and is expected to grow at CAGR of 5.26% by 2027 Manual Microtomes segment has highest cagr growth of 5.26%.

Manual Microtomes

Manual Microtomes segment was valued at US $98.47 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $156.24 million by 2027. Manual Microtomes segment represented US $12.05 million opportunity over 2019-2021 and estimated to create US $45.72 million opportunity in 2027 over 2021.

Semi-Automated Microtomes

Semi-Automated Microtomes segment was valued at US $34.40 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $54.58 million by 2027. Semi-Automated Microtomes segment represented US $4.21 million opportunity over 2019-2021 and estimated to create US $15.97 million opportunity in 2027 over 2021.

Fully Automated Microtomes

Fully Automated Microtomes segment was valued at US $9.66 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $15.33 million by 2027. Fully Automated Microtomes segment represented US $1.18 million opportunity over 2019-2021 and estimated to create US $4.49 million opportunity in 2027 over 2021.

End User

Introduction

In 2021, Clinical Laboratories segment has the highest revenue of US $69.25 million and is expected to grow at CAGR of 5.26% by 2027 Hospital Laboratories segment has highest cagr growth of 5.26%.

Hospital Laboratories

Hospital Laboratories segment was valued at US $60.27 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $95.62 million by 2027. Hospital Laboratories segment represented US $7.37 million opportunity over 2019-2021 and estimated to create US $27.98 million opportunity in 2027 over 2021.

Clinical Laboratories

Clinical Laboratories segment was valued at US $61.71 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $97.90 million by 2027. Clinical Laboratories segment represented US $7.55 million opportunity over 2019-2021 and estimated to create US $28.65 million opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $20.56 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $32.62 million by 2027. Other End Users segment represented US $2.52 million opportunity over 2019-2021 and estimated to create US $9.55 million opportunity in 2027 over 2021.

Region

Introduction

In 2021, North America segment has the highest revenue of US $62.16 million and is expected to grow at CAGR of 5.26% by 2027 North America segment has highest cagr growth of 5.26%.

North America

North America segment was valued at US $55.39 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $87.88 million by 2027. North America segment represented US $6.78 million opportunity over 2019-2021 and estimated to create US $25.72 million opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $41.19 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $65.35 million by 2027. Europe segment represented US $5.04 million opportunity over 2019-2021 and estimated to create US $19.12 million opportunity in 2027 over 2021.

Asia Pacific

Asia Pacific segment was valued at US $22.99 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $36.48 million by 2027. Asia Pacific segment represented US $2.81 million opportunity over 2019-2021 and estimated to create US $10.68 million opportunity in 2027 over 2021.

Rest of the World

Rest of the World segment was valued at US $22.97 million in 2019 and is projected to grow at 5.26% CAGR over the forecast period to reach US $36.44 million by 2027. Rest of the World segment represented US $2.81 million opportunity over 2019-2021 and estimated to create US $10.66 million opportunity in 2027 over 2021.